中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
—— |
gageopeptin B |
—— |
C52H91N7O13 |
|
—— |
kakeromamide A |
—— |
C42H58N6O7S |
|
—— |
nodupetide |
—— |
C28H49N5O7 |
|
—— |
urumamide |
—— |
C51H90N8O10 |
|
—— |
odobromoamide |
—— |
C37H59BrN4O8 |
|
—— |
gageopeptin A |
—— |
C53H93N7O13 |
|
—— |
cereulide |
157232-64-9 |
C57H96N6O18 |
|
—— |
Boc-Pst-Glu-Phe-OH |
—— |
C30H39N3O9 |
|
—— |
hikiamide A |
—— |
C36H50N4O6 |
|
—— |
N-Cbz-leucyl-3(R)-amino-2(R,S)-hydroxy-4-phenylbutyric acid ethyl amide |
—— |
C26H35N3O5 |
|
—— |
(S)-2-(5-(4-(2-(methylthio)phenyl)piperazin-1-yl)pentanoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide |
—— |
C26H34N4O2S |
|
—— |
4-[[(2,6-Dichlorophenyl)carbonyl]amino]-N-[[1-[2-[(methylsulfonyl)amino]ethyl]cyclopentyl]carbonyl]-L-phenylalanine |
—— |
C25H29Cl2N3O6S |
|
—— |
(S)-2-((S)-2-{2-[(S)-1-((S)-1-Methoxycarbonyl-2-methyl-propylcarbamoyl)-2-phenyl-ethylcarbamoyl]-acetylamino}-3-phenyl-propionylamino)-3-methyl-butyric acid methyl ester |
—— |
C33H44N4O8 |
|
—— |
3-(S)-<<4-<<4-(aminoiminomethyl)phenyl>amino>-4-oxobutyl>amino>-4-pentenoic acid |
—— |
C16H22N4O3 |
|
—— |
4-((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl) 2-methyl (2S,4S,5R)-1-((2S,3R,5R)-2-(2-chlorophenyl)-5-(methoxycarbonyl)pyrrolidine-3-carbonyl)-5-(2-fluorophenyl)pyrrolidine-2,4-dicarboxylate |
—— |
C36H44ClFN2O7 |
|
—— |
(S)-2-(1-((2-(((benzyloxy)carbonyl)amino)propanamido)methyl)cyclohexyl)acetic acid |
1554303-33-1 |
C20H28N2O5 |
|
—— |
4-((S)-3-amino-3-((S)-5,6-difluoro-2,3-dihydro-1H-inden-1-yl)propanoyl)-4,5-dihydro-1H-benzo[e][1,4]diazepin-2(3H)-one |
—— |
C21H21F2N3O2 |
|
—— |
onchidin |
—— |
C60H98N6O14 |
|
—— |
pentanoic acid, 3-chloro-N-[(2E,5S,6S)-5-hydroxy-6-[(2S,3S)-3-[4-(hydroxymethyl)phenyl]oxiranyl]-1-oxo-2-heptenyl]-O-methyl-D-tyrosyl-2,2-dimethyl-β-alanyl-2-hydroxy-4-methyl-, (3->1<sup>5</sup>)-lactone, (2S)- |
—— |
C37H47ClN2O9 |
|
—— |
GRL-7234 |
940948-68-5 |
C36H55N5O7S |
|
—— |
2-[(3-Amino-3-methyl-1-oxobutyl)amino]-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]acetamide |
—— |
C21H25N7O2 |
|
—— |
1-(6-Amino-9H-purin-9-yl)-1,3-dideoxy-3-(N-formyl-L-phenylalanylamino)-β-D-ribofuranuronic acid |
—— |
C20H21N7O6 |
|
—— |
(S)-N-((S)-3-amino-1-cyano-3-oxopropyl)-1-((3’-fluoro-[1,1’-biphenyl]-4-yl)sulfonyl)pyrrolidine-2-carboxamide |
—— |
C21H21FN4O4S |
|
—— |
3-((R)-2-((R)-2-(3,4-dichlorophenyl)-4-(6-fluoro-1-methyl-2-oxo-1,2-dihydrospiro[benzo[d][1,3]oxazine-4,4'-piperidine]-1'-yl)-N,2-dimethylbutanamido)-3-phenylpropanamido)propan-1-aminium trifluoroacetate |
—— |
(x)C2HF3O2*C37H44Cl2FN5O4 |
|
—— |
<3(S)-<2-(piperidin-4-yl)ethyl>-2-oxopiperidinyl>acetyl-β-alanine |
—— |
C17H29N3O4 |
|
—— |
<3(R)-<2-(piperidin-4-yl)ethyl>-2-oxopiperidinyl>acetyl-β-alanine |
—— |
C17H29N3O4 |
|
—— |
(S)-1-(((S)-1-(((S,E)-5-((S)-2-benzyl-3-methoxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-5-oxo-1-phenylpent-3-en-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl dimethyl-L-phenylalaninate |
—— |
C46H58N4O7 |
|
—— |
(S)-1-(((S)-1-(((S,E)-5-((R)-2-benzyl-3-methoxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-5-oxo-1-phenylpent-3-en-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl dimethyl-L-phenylalinate |
—— |
C46H58N4O7 |
|
—— |
N-{(R)-1-(4-Chloro-benzyl)-2-[4-(2-cyclohexyl-1-diethylaminomethyl-ethyl)-piperazin-1-yl]-2-oxo-ethyl}-2-(2,3-dihydro-1H-isoindol-1-yl)-acetamide |
—— |
C36H52ClN5O2 |
|
—— |
Boc-β-Ala-Phg-OMe |
—— |
C17H24N2O5 |
|
—— |
benzyl ((2S)-1-(((2S)-1-(((3S)-2-hydroxy-5-methyl-1-morpholino-1-oxohexan-3-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)carbamate |
—— |
C31H50N4O7 |
|
—— |
(S)-1-(5-(4-(2-(methylthio)phenyl)piperazin-1-yl)pentanoyl)pyrrolidine-2-carboxamide |
—— |
C21H32N4O2S |
|
—— |
<i>N</i>-benzyloxycarbonyl-glycyl=>glycyl=><i>N</i>-methyl-glycine benzyl ester |
—— |
C22H25N3O6 |
|
—— |
seribunamide A |
—— |
C29H43Br3N6O7 |
|
—— |
(2S,3aS,7aS)-1-((R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-N-cyclopropyloctahydro-1H-indole-2-carboxamide |
—— |
C22H28F3N3O2 |
|
—— |
(3S,7S,10S,13S)-3-((3aR,6S,6aR)-6-(benzyloxy)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)-7-(3-(benzyloxy)-3-oxopropyl)-13-sec-butyl-10-methyl-5,8,11-trioxo-1-phenyl-2,6,9,12-tetraazatetradecan-14-oic acid |
—— |
C45H58N4O11 |
|
—— |
des-thiomethyllooekeyolide A |
—— |
C31H55NO11 |
|
—— |
A54556 factor E |
—— |
C35H46N6O8 |
|
—— |
cyclo-(γ-ImPyPyPy-(R)<sup>H2N</sup>γ-ImPyPyPy-) |
—— |
C54H61N21O10 |
|
—— |
(1S,4S,7R,10S,13S,14R,15E,17E,19R,21R)-7-(3-bromo-4-hydroxybenzyl)-4-((S)-sec-butyl)-10-(2-hydroxypropan-2-yl)-19-methoxy-1,3,14,18-tetramethyl-13-phenyl-12,22-dioxa-3,6,9-triazabicyclo[19.1.0]docosa-15,17-diene-2,5,8,11-tetraone |
—— |
C42H56BrN3O9 |
|
—— |
(1R,4S,7R,10S,13S,14R,15E,17E,19R,21S)-7-(3-bromo-4-hydroxybenzyl)-4-((S)-sec-butyl)-10-(2-hydroxypropan-2-yl)-19-methoxy-1,3,14,18-tetramethyl-13-phenyl-12,22-dioxa-3,6,9-triazabicyclo[19.1.0]docosa-15,17-diene-2,5,8,11-tetraone |
—— |
C42H56BrN3O9 |
|
—— |
[2H]-Telaprevir |
—— |
C36H53N7O6 |
|
—— |
apratoxin F |
—— |
C44H69N5O8S |
|
—— |
(S)-N-((3R,4S,5S)-1-((S)-2-((1R,2R)-3-((4-aminophenyl)sulfonamido)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)-2-((S)-2-(dimethylamino)-3-methylbutanamido)-N,3-dimethylbutanamide |
—— |
C37H64N6O8S |
|
—— |
tert-butyl (2-((2-(benzylamino)-2-oxoethyl)(methyl)amino)-2-oxoethyl)(methyl)carbamate |
—— |
C18H27N3O4 |
|
—— |
(R)-N-(2-((7-chloro-2-oxo-1,2-dihydroquinoline)-6-sulfonamido)-2-(2-methoxyphenyl)acetyl)-N-(thiophen-2-ylmethyl)glycine |
—— |
C25H22ClN3O7S2 |
|
—— |
1-((2R)-3-cycIopentyI-2-{[formyI(hydroxy)amino]methyl}propanoyl)-N-(cycIopropylcarbonyl)-L-prolinamide |
—— |
C19H29N3O5 |
|
—— |
[Benzyl-((S)-5-methyl-3-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-hexanoyl)-amino]-acetic acid |
—— |
C32H38N4O5 |
|
—— |
diethyl (2S)-2-({3-[(4-{4-[amino(imino)methyl]benzyl}-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)amino]-2-benzyl-3-oxopropanoyl}amino)pentanedioate acetate |
—— |
C2H4O2*C35H39N5O8 |
|
—— |
(S)-N-((S)-3-amino-1-cyano-3-oxopropyl)-1-((4-bromophenyl)sulfonyl)pyrrolidine-2-carboxamide |
—— |
C15H17BrN4O4S |
|